Heart-Type Fatty Acid Binding Protein Level as a Tool in Identification of Early Cardiac Effects of Diabetic Ketoacidosis

J Clin Res Pediatr Endocrinol. 2017 Jun 1;9(2):118-123. doi: 10.4274/jcrpe.3961. Epub 2017 Jan 12.

Abstract

Objective: This study aimed to measure the serum levels of heart-type fatty acid binding protein (H-FABP) in patients presenting with diabetic ketoacidosis (DKA) and diabetic ketosis (DK) and to determine its role in identifying early-period cardiac ischemia.

Methods: This prospective study included 35 patients diagnosed with DKA, 20 patients diagnosed with DK, and 20 control subjects. H-FABP, creatine kinase-MB (CK-MB), and troponin I levels were investigated at presentation in patients with DKA and DK and in the control group. H-FABP values were measured again after acidosis correction in the DKA patients.

Results: No statistically significant differences were found with respect to troponin I and CK-MB within the groups. The H-FABP values of DKA patients at presentation were found to be significantly higher than those of DK patients and the control group (p=0.015). The H-FABP value of the DKA group was also found to be significantly higher than the value at hour 36 after acidosis correction (p=0.0001).

Conclusion: We would like to propose H-FABP as a potential marker for indicating myocardial ischemia.

Keywords: Heart-type fatty acid binding protein; child diabetic ketoacidosis..

MeSH terms

  • Adolescent
  • Biomarkers / blood*
  • Child
  • Child, Preschool
  • Creatine Kinase, MB Form / blood
  • Diabetic Ketoacidosis / blood*
  • Diabetic Ketoacidosis / diagnosis
  • Diabetic Ketoacidosis / etiology
  • Early Diagnosis
  • Fatty Acid Binding Protein 3 / blood*
  • Female
  • Humans
  • Male
  • Myocardial Ischemia / blood*
  • Myocardial Ischemia / complications
  • Myocardial Ischemia / diagnosis
  • Prospective Studies
  • Troponin I / blood

Substances

  • Biomarkers
  • Fatty Acid Binding Protein 3
  • Troponin I
  • Creatine Kinase, MB Form